颈部PET/CT阳性对生存结局的影响——视觉与定量评估:ACRIN 6685研究结果
ACRIN 6685前瞻性研究纳入287例cN0头颈癌患者,208例可分析,评估颈部FDG摄取视觉评估与SUVmax对无复发生存(RFS)和总生存(OS)的影响。视觉评估与RFS显著相关(HR 2.30,95%CI 1.10-4.79,P=0.02),与OS无显著相关。SUVmax阈值5.0与OS和RFS均显著相关。
要点
- 颈部FDG视觉评估与RFS显著相关(HR 2.30,95%CI 1.10-4.79,P=0.02),与OS无显著相关。
- SUVmax阈值5.0与RFS显著相关(HR 5.92,95%CI 1.79-19.57,P<0.001)。
- 在30%测试数据中,SUVmax阈值5.0与OS显著相关(HR 3.42,95%CI 1.03-11.41,P=0.03)。
核心结论
- 颈部FDG摄取视觉评估对RFS有显著意义。
- SUVmax阈值5.0与OS和RFS均显著相关。
研究设计与样本
- ACRIN 6685前瞻性研究纳入287例cN0头颈癌患者,208例有可分析数据。
- 基于颈部FDG视觉评估和SUVmax进行生存分析,比较RFS和OS。
- SUVmax最佳阈值通过条件推断树在随机选取的70%训练数据集上计算,并在剩余30%数据上验证。
- 生成Kaplan-Meier曲线及log-rank检验,计算风险比(HR)和95%置信区间(CI),假设检验显著性水平为0.05。
主要发现
- 研究结束时,双侧cN0患者73.9%存活,单侧cN0患者50.0%存活,其余为死亡或失访。
- OS中位随访时间24.0个月(四分位距15.8-25.3;范围0-37.0)。
- 双侧cN0患者63.3%、单侧cN0患者42.5%在研究期间保持无病。
- RFS中位随访时间23.9个月(四分位距12.4-25.2;范围0-35.6)。
- 视觉评估与RFS显著相关(HR 2.30,95%CI 1.10-4.79;P=0.02),与OS无显著相关(HR 1.64,95%CI 0.86-3.14;P=0.13)。
关键数值与推荐
- RFS的最佳SUVmax阈值为2.5,OS的最佳SUVmax阈值为5.0。
- 在30%测试数据中应用最佳阈值,RFS的HR为2.09(95%CI 0.61-7.14;P=0.23),OS的HR为3.42(95%CI 1.03-11.41;P=0.03)。
- SUVmax阈值5.0与RFS显著相关(HR 5.92,95%CI 1.79-19.57;P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: FDG PET/CT was prospectively studied in 287 cN0 head and neck cancer patients in ACRIN 6685, and additional analysis of neck FDG uptake upon recurrence-free survival (RFS) and overall survival (OS) was performed. PATIENTS AND METHODS: Two hundred eight had analyzable data. Survival analysis was performed to compare RFS and OS based on neck FDG visual assessment (VA) and SUV max . For SUV max , the optimal thresholds were calculated using conditional inference trees on a randomly selected 70% training data set and validated using the remaining 30% of data. Kaplan-Meier curves with log-rank tests were generated for the patient groups based on VA and optimal SUV max thresholds, and the hazards ratios (HRs) and 95% confidence intervals (CIs) were also calculated. Hypothesis testing was set at a significance level of 0.05. RESULTS: A total of 73.9% of bilateral cN0 and 50.0% of unilateral cN0 were alive at the end of the study with the remaining being dead or lost to follow-up. Overall survival median follow-up time was 24.0 months (interquartile range, 15.8-25.3; range, 0-37.0). A total of 63.3% of bilateral cN0 and 42.5% of unilateral cN0 patients remained disease free during the study. Recurrence-free survival median follow-up time was 23.9 months (interquartile range, 12.4-25.2; range, 0-35.6). Visual assessment of necks by our panel of radiologists was significantly associated with RFS (HR [95% CI], 2.30 [1.10-4.79]; P = 0.02), but not with OS (HR [95% CI], 1.64 [0.86-3.14]; P = 0.13). The optimal SUV max thresholds were 2.5 for RFS and 5.0 for OS. For SUV max assessment, applying the optimal thresholds to the 30% test data yielded HRs (95% CIs) of 2.09 (0.61-7.14; P = 0.23) for RFS and 3.42 (1.03-11.41; P = 0.03) for OS. The SUV max threshold of 5.0 was significantly associated with RFS (HR [95% CI], 5.92 [1.79-19.57]; P < 0.001). CONCLUSIONS: Neck FDG uptake by VA is significant for RFS. An SUV max threshold of 5.0 is significantly associated with OS and RFS.
引用
- Stack BC, Duan F, Romanoff J, et al. Impact of Neck PET/CT Positivity on Survival Outcomes-Visual and Quantitative Assessment: Results From ACRIN 6685. Clin Nucl Med. 2022. PMID: 36562743. doi:10.1097/RLU.0000000000004483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。